These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9439743)

  • 21. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
    Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
    J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotransmitters and second messengers in aging and Alzheimer's disease.
    Francis PT; Webster MT; Chessell IP; Holmes C; Stratmann GC; Procter AW; Cross AJ; Green AR; Bowen DM
    Ann N Y Acad Sci; 1993 Sep; 695():19-26. PubMed ID: 7902054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease.
    Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B
    Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice.
    Li WZ; Li WP; Yao YY; Zhang W; Yin YY; Wu GC; Gong HL
    Eur J Pharmacol; 2010 Feb; 628(1-3):108-15. PubMed ID: 19948164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients.
    Harris CD; Ermak G; Davies KJ
    FEBS J; 2007 Apr; 274(7):1715-24. PubMed ID: 17331188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White matter lesions and hippocampal atrophy in Alzheimer's disease.
    de Leeuw FE; Barkhof F; Scheltens P
    Neurology; 2004 Jan; 62(2):310-2. PubMed ID: 14745078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer's disease.
    Arendt T; Bigl V; Tennstedt A; Arendt A
    Neurosci Lett; 1984 Jul; 48(1):81-5. PubMed ID: 6472737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Senile dementia of Alzheimer type characterized by laminar neuronal loss exclusively in the hippocampus, parahippocampus and medial occipitotemporal cortex.
    Mizutani T; Amano N; Sasaki H; Morimatsu Y; Mori H; Yoshimura M; Yamanouchi H; Hayakawa K; Shimada H
    Acta Neuropathol; 1990; 80(6):575-80. PubMed ID: 2275334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex.
    Quigley BJ; Kowall NW
    Neuroscience; 1991; 41(1):41-60. PubMed ID: 1711654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer's disease.
    Dawbarn D; Emson PC
    Biochem Biophys Res Commun; 1985 Jan; 126(1):289-94. PubMed ID: 3838246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plaques, tangles and Alzheimer's disease.
    Tomlinson BE
    Psychol Med; 1982 Aug; 12(3):449-59. PubMed ID: 7134306
    [No Abstract]   [Full Text] [Related]  

  • 32. Morphological and morphometric alterations of Cajal-Retzius cells in early cases of Alzheimer's disease: a Golgi and electron microscope study.
    Baloyannis SJ
    Int J Neurosci; 2005 Jul; 115(7):965-80. PubMed ID: 16051543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of neuronal oxidative damage in Alzheimer's disease.
    Good PF; Werner P; Hsu A; Olanow CW; Perl DP
    Am J Pathol; 1996 Jul; 149(1):21-8. PubMed ID: 8686745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts.
    Zilles K; Qü M; Schleicher A; Schroeter M; Kraemer M; Witte OW
    Arzneimittelforschung; 1995 Mar; 45(3A):361-6. PubMed ID: 7763327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.
    Hartmann HA
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):507. PubMed ID: 2439658
    [No Abstract]   [Full Text] [Related]  

  • 36. Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats.
    Olajide OJ; Asogwa NT; Moses BO; Oyegbola CB
    Metab Brain Dis; 2017 Aug; 32(4):1147-1161. PubMed ID: 28405779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutamate receptors in human caudate nucleus in normal aging and Alzheimer's disease.
    Tsamis KI; Mytilinaios DG; Njau SN; Baloyannis SJ
    Curr Alzheimer Res; 2013 Jun; 10(5):469-75. PubMed ID: 23627706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts.
    Giannakopoulos P; Hof PR; Michel JP; Guimon J; Bouras C
    Brain Res Brain Res Rev; 1997 Oct; 25(2):217-45. PubMed ID: 9403139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hippocampal-sparing Alzheimer's disease presenting as corticobasal syndrome.
    Malkani RG; Dickson DW; Simuni T
    Parkinsonism Relat Disord; 2012 Jun; 18(5):683-5. PubMed ID: 22172552
    [No Abstract]   [Full Text] [Related]  

  • 40. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
    Hyman BT; Van Hoesen GW; Damasio AR; Barnes CL
    Science; 1984 Sep; 225(4667):1168-70. PubMed ID: 6474172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.